Lopid (Gemfibrozil)

This is a medicine used to help lower high levels of fat (lipids) in your blood. It works mainly by reducing the amount of triglycerides, which are a type of fat. It can also help lower total cholesterol. It's often used to help prevent heart attacks and strokes in people with high cholesterol or triglycerides.

Brand names:Lopid
Medication

What people taking Lopid (Gemfibrozil) report

Every report comes from a Lived member, sent anonymously.

Have you tried Lopid (Gemfibrozil) for High Triglycerides?

NameHow it went

About Lopid (Gemfibrozil)

What It's For

Gemfibrozil, sold as Lopid and as a generic, is a prescription medicine that lowers triglycerides, a type of fat carried in the blood. It belongs to a group of lipid-lowering medicines called fibrates and is meant to be used alongside diet changes, not instead of them. Its main use is for adults with very high triglycerides who are at risk of pancreatitis, a painful and sometimes serious inflammation of the pancreas. For context, a triglyceride level under 150 mg/dL (milligrams per deciliter) is considered healthy, and 500 mg/dL or higher is very high. The risk of pancreatitis rises mainly above about 2,000 mg/dL and is unlikely when levels stay below 1,000 mg/dL. Between those levels, gemfibrozil may be considered for people who have already had pancreatitis or repeated abdominal pain typical of it. Gemfibrozil is also approved to lower the risk of coronary heart disease in a narrow group: people without known heart disease who have a particular combination of high LDL ("bad") cholesterol, high triglycerides and low HDL ("good") cholesterol, and who have not done well enough with weight loss, diet, exercise and other cholesterol medicines. In a large study of middle-aged Finnish men with this kind of profile, it reduced heart attacks and sudden cardiac deaths over five years, although deaths from all causes were not lower, and a parallel study in men who already had heart disease showed no benefit. It is not meant for people whose only problem is high LDL cholesterol or low HDL cholesterol.

How It Works

The liver packages triglycerides into particles called VLDL (very-low-density lipoprotein), which carry fat through the bloodstream to the body's tissues. Gemfibrozil reduces the amount of fat that reaches the liver from fat tissue and slows the liver's production of these particles, while speeding their removal. The result is less triglyceride in the blood. Gemfibrozil also tends to raise HDL cholesterol. Its effect on LDL cholesterol is less predictable. In people with very high triglycerides, LDL can rise as triglycerides fall, which is one reason the full lipid profile is rechecked after starting. Researchers have not fully established exactly how gemfibrozil produces all of these effects.

Dosage & Administration

Gemfibrozil comes as a 600 mg tablet. The usual adult dose is 1,200 mg a day, taken as two 600 mg doses: one about 30 minutes before breakfast and one about 30 minutes before the evening meal. Taking it at around the same times each day keeps the routine simple. If you also take a bile acid binder such as colestipol (a cholesterol medicine that works in the gut), take the two at least two hours apart, because taking them together reduces how much gemfibrozil the body absorbs. If you miss a dose, take it when you remember unless the next dose is nearly due, and do not take two doses at once to catch up.

Side Effects

Digestive symptoms are the most common, especially indigestion and stomach pain. In the large Finnish study, about a third of people taking gemfibrozil reported digestive complaints, compared with about a quarter of those taking a placebo (a dummy pill). Diarrhea, nausea, tiredness, rash, dizziness, headache, tingling or numbness, and a changed sense of taste have also been reported. Heartburn or stomach pain that is severe or does not go away is worth mentioning to the prescriber. Gemfibrozil increases the amount of cholesterol released into bile, which raises the chance of gallstones. If gallstones are found, the medicine is usually stopped. Severe upper abdominal pain, particularly with nausea or vomiting, needs prompt medical attention, because it can signal pancreatitis or an inflamed gallbladder rather than an ordinary side effect. Muscle pain, tenderness or weakness should be reported to the prescriber right away. Fibrates can occasionally inflame muscles, and in rare cases this progresses to rhabdomyolysis, a breakdown of muscle tissue that can damage the kidneys. Blurred vision should also prompt a call to the prescriber right away.

Interactions & Warnings

Gemfibrozil changes how the body clears many other medicines, so the prescriber and pharmacist need a complete list before it starts. Some combinations should not be used at all. Simvastatin, a statin cholesterol medicine, is ruled out because the pair sharply raises the risk of severe muscle damage. Repaglinide, a diabetes pill, is ruled out because blood sugar can drop dangerously low. Selexipag, used for pulmonary arterial hypertension, and dasabuvir, an older hepatitis C medicine, are also not to be combined with it. Combining gemfibrozil with any statin raises the risk of muscle injury and, in some cases, kidney failure, and problems have appeared anywhere from three weeks to several months after starting. The label advises avoiding rosuvastatin, or keeping it at a low dose if the combination cannot be avoided. Warfarin, a blood thinner, becomes stronger with gemfibrozil, so its dose usually has to be lowered and clotting tests checked more often until results are stable. Gemfibrozil can also raise blood levels of other medicines enough to need a dose change, including some diabetes pills such as pioglitazone and glyburide, the asthma medicine montelukast, the prostate cancer medicine enzalutamide and the anti-diarrhea medicine loperamide. Colchicine, a gout medicine, adds to the muscle risk, especially in older adults and people with kidney disease. Gemfibrozil should not be used by people with liver disease, severe kidney disease or existing gallbladder disease, and it can worsen kidney function in people whose kidneys are already significantly impaired. Animal studies showed harm in pregnancy and there are no adequate human studies, so it is used only when the benefit clearly justifies the risk. It is unknown whether gemfibrozil passes into breast milk, and because of tumor findings in animal studies, the label advises choosing between breastfeeding and taking the medicine. Anyone who is breastfeeding or plans to should discuss this with the prescriber. Its safety in children has not been established. There is also a longer-term caution. In the follow-up to the Finnish study, deaths from causes other than heart disease, mostly cancer, were somewhat higher in the group first assigned to gemfibrozil, although the difference could have been due to chance. A closely related older fibrate, clofibrate, increased deaths overall in an earlier trial. For these reasons the label limits gemfibrozil to the specific groups it is approved for.

What to Expect

Triglyceride levels usually fall with gemfibrozil, and the prescriber checks a lipid panel (a blood test of cholesterol and triglycerides) to confirm it. The label advises stopping the medicine if lipid levels have not responded adequately after three months, rather than continuing it without a clear benefit. Follow-up also includes periodic liver tests and, during the first year, blood counts. Gemfibrozil occasionally raises liver enzymes, and these changes usually reverse once it is stopped; in rare cases it lowers red cells, white cells or platelets. Diet, limiting alcohol, weight management and treating conditions that drive triglycerides up, such as poorly controlled diabetes or an underactive thyroid, remain part of the plan. Estrogen therapy can sometimes push triglycerides very high, so the prescriber may review it as well. When gemfibrozil works and is well tolerated, it is usually taken long term. It controls triglycerides but does not cure the underlying problem, so stopping it is a decision to make with the prescriber.

Questions to Ask Your Doctor

  1. 1.Given my triglyceride level and any history of pancreatitis, why is gemfibrozil a better fit for me than another fibrate, an omega-3 medicine or lifestyle changes alone?
  2. 2.I take a statin, or may need one. How does that affect whether gemfibrozil is safe for me?
  3. 3.Which of my other medicines, such as warfarin or diabetes pills, need a dose change or extra monitoring?
  4. 4.Which blood tests will show whether it is working, and when would we decide to stop it?
  5. 5.What symptoms, such as muscle pain or abdominal pain, should make me call you right away?

Last reviewed • Oct 2026

Educational content, not medical advice.